NL-OMON37817已完成不适用
SINGLE CENTER, OPEN LABEL, RANDOMIZED TWO-WAY CROSSOVER STUDY OF THE EFFECT OF LACOSAMIDE 200MG TWICE DAILY ON THE SINGLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN (25 MG) IN HEALTHY MALE VOLUNTEERS - Lacosamide/Warfarin DDI study.
CB Pharma0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy Male between18-55 yrs,,
- •18.0-30.0 kg/m2, with a body weight of at least 50 kg.
- •Non-smoking
排除标准
- •Suffering from: hepatitis B, C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study or in case of donating more than 1.5 liter of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
SINGLE-CENTER, OPEN-LABEL, RANDOMIZED, TWO-PARTS, TWO-WAY CROSSOVER STUDY TO INVESTIGATE THE EFFECTS ON HEART RATE, BLOOD PRESSURE, AND PHARMACOKINETIC INTERACTIONS OF ACT-128800 COMBINED WITH A CALCIUM-CHANNEL BLOCKER OR A BETA-BLOCKER IN HEALTHY SUBJECTSImmune disease10027665NL-OMON36345Actelion Pharmaceuticals24
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, OPEN LABEL, SINGLE AND MULTIPLE DOSE STUDY OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 DOSE LEVELS OF PANTOPRAZOLE SODIUM ENTERIC-COATED SPHEROID SUSPENSION IN INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERD.INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERDEUCTR2006-001132-45-DEWyeth Research Division of Wyeth Pharmaceuticals Inc, Clinical Research and Development56
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, OPEN LABEL, SINGLE AND MULTIPLE DOSE STUDY OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 DOSE LEVELS OF PANTOPRAZOLE SODIUM ENTERIC-COATED SPHEROID SUSPENSION IN INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERD.EUCTR2006-001132-45-BEWyeth Research Division of Wyeth Pharmaceuticals Inc, Clinical Research and Development56
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, OPEN LABEL, SINGLE AND MULTIPLE DOSE STUDY OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 DOSE LEVELS OF PANTOPRAZOLE SODIUM ENTERIC-COATED SPHEROID SUSPENSION IN INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERD - NDINFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERDMedDRA version: 9.1Level: LLTClassification code 10017885Term: Gastrooesophageal reflux diseaseEUCTR2006-001132-45-ITWyeth Pharmaceuticals Inc., Wyeth Research Div., Clinical research and Development56
进行中（未招募）
1 期
A MULTICENTER, RANDOMIZED, OPEN LABEL, SINGLE AND MULTIPLE DOSE STUDY OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 DOSE LEVELS OF PANTOPRAZOLE SODIUM ENTERIC-COATED SPHEROID SUSPENSION IN INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERD.INFANTS AGED 1 THROUGH 11 MONTHS WITH PRESUMED GERDEUCTR2006-001132-45-FRWyeth Research Division of Wyeth Pharmaceuticals Inc, Clinical Research and Development56